Caroline Hojer is the Director of the Munich Antibody Platform at BioNTech, a position they currently hold. Previously, they served as the Sub Chapter Lead in Protein Chemistry and Group Leader in Antibody Development at Roche from 2021 to 2023. With a strong foundation in oncology and cancer biology, Caroline worked as a Scientist at U3 Pharma from 2013 to 2016 and completed a postdoctoral research fellowship at Genentech from 2009 to 2013. Caroline earned a Ph.D. in Oncology and Cancer Biology and a Diploma in Genetics from Ludwig-Maximilians Universität München, further enhancing their expertise in the field.
This person is not in any teams
This person is not in any offices